Literature DB >> 24699942

Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells.

Kengo Imanishi1, Mihoko Sutoh Yoneyama1, Shingo Hatakeyama1, Hayato Yamamoto1, Takuya Koie1, Hisao Saitoh2, Kanemitsu Yamaya2, Tomihisa Funyu2, Toshiya Nakamura3, Chikara Ohyama1, Shigeru Tsuboi1.   

Abstract

Muscle invasive bladder cancer is an aggressive type of epithelial tumor with a high rate of metastasis. For bladder cancer cells to reach the muscle layer, cells must invade through an urothelial cell monolayer (transurothelial invasion) and basement membrane. However, the process by which transurothelial invasion occurs has not been fully characterized. In this study we developed a novel method to evaluate the transurothelial invasion capacity and investigated its cellular and molecular processes using primary culture cells from bladder cancer patients. The analysis revealed that compared with the prognosis for patients with non‑muscle invasive bladder cancer that of patients with muscle invasive bladder cancer was particularly poor due to metastatic recurrence. Cancer cells from patients with muscle invasive bladder cancer exhibited a higher invasive capacity through the urothelial cell monolayer compared with those from non‑invasive bladder cancer patients. Furthermore, muscle invasive bladder cancer cells demonstrated a greater ability to form invadopodia, the filamentous actin‑based membrane protrusions required for matrix degradation and invasion compared with non‑invasive cells. Bladder cancer cell lines were established with reduced invadopodia formation by silencing the expression of cortactin, an essential component of invadopodia. The cortactin knockdown bladder cancer cells with reduced invadopodia formation demonstrated a markedly reduced ability to invade through the urothelial cell monolayer, indicating that invadopodia are essential for transurothelial invasion. The results indicate that invadopodia formation is required for muscle invasion of aggressive bladder cancer cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24699942     DOI: 10.3892/mmr.2014.2113

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  The role of LIM and SH3 protein-1 in bladder cancer metastasis.

Authors:  Misaki Sato; Mihoko Sutoh Yoneyama; Shingo Hatakeyama; Tomihisa Funyu; Tadashi Suzuki; Chikara Ohyama; Shigeru Tsuboi
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

Review 2.  Cancer invasion into musculature: Mechanics, molecules and implications.

Authors:  Lianne Beunk; Kari Brown; Iris Nagtegaal; Peter Friedl; Katarina Wolf
Journal:  Semin Cell Dev Biol       Date:  2018-09-05       Impact factor: 7.727

Review 3.  Cohesive cancer invasion of the biophysical barrier of smooth muscle.

Authors:  William L Harryman; Kendra D Marr; Daniel Hernandez-Cortes; Raymond B Nagle; Joe G N Garcia; Anne E Cress
Journal:  Cancer Metastasis Rev       Date:  2021-01-04       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.